DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Chlorzoxazone is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Glenmark Pharms Ltd, Havix, I3 Pharms, Mayne Pharma, Mikart, Novitium Pharma, Ohm Labs, Par Pharm, Par Pharm Inc, Pioneer Pharms, Rising, Sun Pharm Industries, Teva Pharms Usa Inc, and Watson Labs. and is included in twenty-seven NDAs.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
A generic version of CHLORZOXAZONE was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
Summary for CHLORZOXAZONE
Recent Clinical Trials for CHLORZOXAZONE
Identify potential brand extensions & 505(b)(2) entrants
|University Hospital Olomouc||Phase 2|
|Marian Hajduch, M.D., Ph.D.||Phase 2|